(Q37060593)

18 August 2017

1 reference

title

Targeting of the immune system in systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

18 August 2017

1 reference

Anne Davidson

2

0 references

author name string

Meera Ramanujam

series ordinal

1

1 reference

18 August 2017

21 January 2008

1 reference

Expert Reviews in Molecular Medicine

18 August 2017

1 reference

18 August 2017

10

1 reference

18 August 2017

e2

1 reference

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

18 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The natural interferon-alpha producing cells in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Systemic lupus erythematosus: all roads lead to type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Fcgamma receptors: old friends and new family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Development and maturation of secondary lymphoid tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The TNF and TNF receptor superfamilies: integrating mammalian biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Abetimus sodium (riquent) for the prevention of nephritic flares in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

CTLA4Ig prevents initiation but not evolution of anti-phospholipid syndrome in NZW/BXSB mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Toll-like receptor 9 signaling protects against murine lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Etanercept-induced systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

TNF pathophysiology in murine models of chronic inflammation and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

ICOS-induced B7h shedding on B cells is inhibited by TLR7/8 and TLR9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Systemic lupus erythematosus and the type I interferon system

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The TNF-ligand and receptor superfamilies: controllers of immunity and the Trojan horses of autoimmune disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Immunobiology of Toll-like receptors: emerging trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Interleukin 6 promotes murine lupus in NZB/NZW F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Pathogen recognition and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Rationale for interleukin-6 blockade in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Endogenous TLR ligands and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

All is not Toll: new pathways in DNA recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Interleukin-6: from basic science to medicine--40 years in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The role of complement in the development of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Reprogramming of IL-10 activity and signaling by IFN-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Natural serum IgM maintains immunological homeostasis and prevents autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Novel therapeutics for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

CD22 regulates thymus-independent responses and the lifespan of B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Siglecs and their roles in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

An open study of B lymphocyte depletion in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Rituximab anti-B-cell therapy in systemic lupus erythematosus: pointing to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Apoptosis and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Estrogen alters thresholds for B cell apoptosis and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Mouse CD20 expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Genetics of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The genes of systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Predominant autoantibody production by early human B cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

B cell abnormalities in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

A role for BLyS in the activation of innate immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

B cell immunobiology in disease: evolving concepts from the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

New regulatory co-receptors: inducible co-stimulator and PD-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Regulation of T:B cell interactions by the inducible costimulator molecule: does ICOS "induce" disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

ICOS co-stimulatory receptor is essential for T-cell activation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

ICOS is critical for CD40-mediated antibody class switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Negative co-receptors on lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Treatment of murine lupus with CTLA4Ig

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

IL-17 family cytokines and the expanding diversity of effector T cell lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Block and tackle: CTLA4Ig takes on lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Indoleamine 2,3 dioxygenase and regulation of T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

mTOR at the crossroads of T cell proliferation and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Natural regulatory T cells: mechanisms of suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The role of somatic mutation in the pathogenic anti-DNA response

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Low-affinity, Smith antigen-specific B cells are tolerized by dendritic cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The antiinflammatory activity of IgG: the intravenous IgG paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Unraveling the genetics of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Type-I interferons and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Expression profile of FcgammaRIIb on leukocytes and its dysregulation in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

BAFF and MyD88 signals promote a lupuslike disease independent of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Cutting edge: germinal centers formed in the absence of B cell-activating factor belonging to the TNF family exhibit impaired maturation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Identification of proteoglycans as the APRIL-specific binding partners.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

BCMA is essential for the survival of long-lived bone marrow plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

BAFF AND APRIL: a tutorial on B cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The current status of targeting BAFF/BLyS for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

CD40 and its crucial role as a member of the TNFR family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Recombinant human Dnase I (rhDNase) in patients with lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB × NZW mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

The inhibitory Fcγ receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

T cell tolerance and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Mechanism of Action of Transmembrane Activator and Calcium Modulator Ligand Interactor-Ig in Murine Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition

21 January 2018

2 references

https://api.crossref.org/works/10.1017%2FS1462399408000562

21 January 2018

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

IL-10 regulates murine lupus

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Tumor Necrosis Factor Family Ligands and Receptors in the Immune System: Targets for Future Pharmaceuticals

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

IL-10 regulation of lupus in the NZM2410 murine model

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Toll-like receptors: emerging concepts in kidney disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Re: "collagen-induced arthritis in TNF receptor-1-deficient mice: TNF receptor-2 can modulate arthritis in the absence of TNF receptor 1"

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Cytokines in glomerulonephritis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Timing of IFN-β Exposure during Human Dendritic Cell Maturation and Naive Th Cell Stimulation Has Contrasting Effects on Th1 Subset Generation: A Role for IFN-β-Mediated Regulation of IL-12 Family Cytokines and IL-18 in Naive Th Cell Differentiation

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Restoration of tolerance in lupus by targeted inhibitory receptor expression

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Apoptosis and autoimmunity

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000562

7 January 2021

10.1017/S1462399408000562

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18205972